Recursion Pharmaceuticals (NASDAQ: RXRX) has been a pioneer in using artificial intelligence (AI) to improve the drug ...

AI-based drug developer Recursion’s stock barely moved Wednesday, then dropped Thursday and Friday, after reporting mixed third quarter results, setting the stage for future pipeline announcements—and ...

Operating massive reverse proxy fleets reveals hard lessons: optimizations that work on smaller systems fail at scale; mundane oversights like missing commas cause major outages; and abstractions ...

Jae Bratton has been writing about credit cards for NerdWallet since 2022. Her work has been published in The Washington Post, the Los Angeles Times, The Associated Press and the journal Studies in ...